128 related articles for article (PubMed ID: 7572394)
21. Cyclosporine-induced apoptosis in CD4+ T lymphocytes and computer-simulated analysis: modeling a treatment scenario for HIV infection.
Huss R; Hoy CA; Ottinger H; Grosse-Wilde H; Deeg HJ
Res Immunol; 1995 Feb; 146(2):101-8. PubMed ID: 7481073
[TBL] [Abstract][Full Text] [Related]
22. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
23. The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus.
Borvak J; Chou CS; Van Dyke G; Rosenwirth B; Vitetta ES; Ramilo O
J Infect Dis; 1996 Oct; 174(4):850-3. PubMed ID: 8843228
[TBL] [Abstract][Full Text] [Related]
24. Effect of cyclosporin A, FK506 and rapamycin on proliferation and soluble IL-2 receptor release from mitogenically stimulated rat spleen cells.
Pockley AG; Williams S; Reid SD; Bowles MJ
Biochem Soc Trans; 1995 Nov; 23(4):615S. PubMed ID: 8654800
[No Abstract] [Full Text] [Related]
25. Potential role of immune modulation in the effective long-term control of HIV-1 infection.
Rizzardi GP; Lazzarin A; Pantaleo G
J Biol Regul Homeost Agents; 2002; 16(1):83-90. PubMed ID: 12003181
[TBL] [Abstract][Full Text] [Related]
26. Facilitation of apoptosis by cyclosporins A and H, but not FK506 in mouse bronchial eosinophils.
Kitagaki K; Nagai H; Hayashi S; Totsuka T
Eur J Pharmacol; 1997 Oct; 337(2-3):283-9. PubMed ID: 9430427
[TBL] [Abstract][Full Text] [Related]
27. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
[TBL] [Abstract][Full Text] [Related]
28. [Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients].
Bai YJ; Wang LL; Cai B; Zou YG; Feng WH; Yan LN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):989-92. PubMed ID: 18845086
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context.
Siemann G; Blume R; Grapentin D; Oetjen E; Schwaninger M; Knepel W
Mol Pharmacol; 1999 Jun; 55(6):1094-100. PubMed ID: 10347253
[TBL] [Abstract][Full Text] [Related]
30. [Multiple actions of tacrolimus and cyclosporin A as specific inhibitors of calcineurin].
Tamura K
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1118-30. PubMed ID: 9655970
[No Abstract] [Full Text] [Related]
31. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line.
Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI
Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures.
Igarashi K; Hirotani H; Woo JT; Stern PH
Bone; 2004 Jul; 35(1):47-56. PubMed ID: 15207740
[TBL] [Abstract][Full Text] [Related]
33. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response.
Du S; Hiramatsu N; Hayakawa K; Kasai A; Okamura M; Huang T; Yao J; Takeda M; Araki I; Sawada N; Paton AW; Paton JC; Kitamura M
J Immunol; 2009 Jun; 182(11):7201-11. PubMed ID: 19454717
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporin A and FK506 decrease adenosine kinase activity and adenosine uptake in T-lymphocytes.
Spychala J; Mitchell BS
J Lab Clin Med; 2002 Aug; 140(2):84-91. PubMed ID: 12228764
[TBL] [Abstract][Full Text] [Related]
35. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin.
Wicker LS; Boltz RC; Matt V; Nichols EA; Peterson LB; Sigal NH
Eur J Immunol; 1990 Oct; 20(10):2277-83. PubMed ID: 1700753
[TBL] [Abstract][Full Text] [Related]
36. Biology of cyclosporin A and FK506.
Bierer BE
Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944
[No Abstract] [Full Text] [Related]
37. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.
Szabo G; Gavala C; Mandrekar P
J Investig Med; 2001 Sep; 49(5):442-9. PubMed ID: 11523700
[TBL] [Abstract][Full Text] [Related]
38. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine.
Takahara S; Jiang H; Takano Y; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
Transplantation; 1992 Apr; 53(4):914-8. PubMed ID: 1373537
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro.
Gabryel B; Chalimoniuk M; Stolecka A; Waniek K; Langfort J; Malecki A
J Pharmacol Sci; 2006 Sep; 102(1):77-87. PubMed ID: 16990701
[TBL] [Abstract][Full Text] [Related]
40. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506.
Clipstone NA; Crabtree GR
Ann N Y Acad Sci; 1993 Nov; 696():20-30. PubMed ID: 7509131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
